In pancreatic cancer, PRMT3 enhances chemoresistance by methylating heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1), which stabilizes ABCG2 mRNA [24]. Here, ABCG2 is linked to familial pancreatic carcinoma.